Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ENO3 |
| Upstream (Parents) |
|---|
| (<<) PPP1R1A → ENO3 |
| (<<) PPP1R3C → ENO3 |
| (<<) IGFALS → ENO3 |
| (<<) COX6A2 → ENO3 |
| (<<) UGP2 → ENO3 |
| Downstream (Children) |
|---|
| ENO3 → POU5F1P4///POU5F1P3///POU5F1B///POU5F1 (>>) |
| ENO3 → REG3A (>>) |
| ENO3 → MYOM2 (>>) |
| ENO3 → FAM48A///DES (>>) |
| ENO3 → C10orf12 (>>) |
| ENO3 → RPL3L (>>) |
| ENO3 → FAM125B (>>) |
| ENO3 → CACNA1S (>>) |
| ENO3 → LOC442715 (>>) |
| ENO3 → ATP12A (>>) |
| ENO3 → MYL4 (>>) |
| ENO3 → CACNG1 (>>) |
| ENO3 → COX6A2 (>>) |
| ENO3 → AAGAB (>>) |
